58 related articles for article (PubMed ID: 23537056)
1. Hepatocellular carcinoma as extracolonic manifestation of Lynch syndrome indicates SEC63 as potential target gene in hepatocarcinogenesis.
Casper M; Weber SN; Kloor M; Müllenbach R; Grobholz R; Lammert F; Zimmer V
Scand J Gastroenterol; 2013 Mar; 48(3):344-51. PubMed ID: 23537056
[TBL] [Abstract][Full Text] [Related]
2. TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms.
Esparza-Baquer A; Labiano I; Sharif O; Agirre-Lizaso A; Oakley F; Rodrigues PM; Zhuravleva E; O'Rourke CJ; Hijona E; Jimenez-Agüero R; Riaño I; Landa A; La Casta A; Zaki MYW; Munoz-Garrido P; Azkargorta M; Elortza F; Vogel A; Schabbauer G; Aspichueta P; Andersen JB; Knapp S; Mann DA; Bujanda L; Banales JM; Perugorria MJ
Gut; 2021 Jul; 70(7):1345-1361. PubMed ID: 32907830
[TBL] [Abstract][Full Text] [Related]
3. Muir-Torre Syndrome With a Frame-shift Mutation in the MSH2 Gene: A Rare Case Report and Literature Review.
Chen Q; Wang M; Xu Z; Wang M; Jin S; Tian S; Xiao S
Int J Gynecol Pathol; 2020 Mar; 39(2):136-140. PubMed ID: 32039937
[TBL] [Abstract][Full Text] [Related]
4. A locally advanced colon cancer patient with Muir-Torre syndrome obtains durable response to neoadjuvant and adjuvant immunotherapy.
Guo Z; Cai Y; Yin W; Huang J
Tumori; 2023 Dec; 109(6):NP27-NP31. PubMed ID: 37880978
[TBL] [Abstract][Full Text] [Related]
5. Diethylnitrosamine Induction of Hepatocarcinogenesis in Mice.
Sotty J; Bablon P; Weiss PH; Soussan P
Methods Mol Biol; 2024; 2769():15-25. PubMed ID: 38315386
[TBL] [Abstract][Full Text] [Related]
6. Hyperpolyploidization of hepatocyte initiates preneoplastic lesion formation in the liver.
Lin H; Huang YS; Fustin JM; Doi M; Chen H; Lai HH; Lin SH; Lee YL; King PC; Hou HS; Chen HW; Young PY; Chao HW
Nat Commun; 2021 Jan; 12(1):645. PubMed ID: 33510150
[TBL] [Abstract][Full Text] [Related]
7. Gender dimorphism in hepatocarcinogenesis-DNA methylation modification regulated X-chromosome inactivation escape molecule XIST.
Dai Z; Wang S; Guo X; Wang Y; Yin H; Tan J; Mu C; Sun SH; Liu H; Yang F
Clin Transl Med; 2023 Dec; 13(12):e1518. PubMed ID: 38148658
[TBL] [Abstract][Full Text] [Related]
8. Loss of hepatic Sirt7 accelerates diethylnitrosamine (DEN)-induced formation of hepatocellular carcinoma by impairing DNA damage repair.
Kim Y; Kang BE; Gariani K; Gariani J; Lee J; Kim HJ; Lee CW; Schoonjans K; Auwerx J; Ryu D
BMB Rep; 2024 Feb; 57(2):98-103. PubMed ID: 38303560
[TBL] [Abstract][Full Text] [Related]
9. Research Advances in the Role of the Tropomyosin Family in Cancer.
Meng Y; Huang K; Shi M; Huo Y; Han L; Liu B; Li Y
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686101
[TBL] [Abstract][Full Text] [Related]
10. Sec61γ is a vital protein in the endoplasmic reticulum membrane promoting tumor metastasis and invasion in lung adenocarcinoma.
Xu S; Li X; Geng J; Cao Y; Yu Y; Qi L
Br J Cancer; 2023 Apr; 128(8):1478-1490. PubMed ID: 36759724
[TBL] [Abstract][Full Text] [Related]
11. The endoplasmic reticulum membrane protein Sec62 as potential therapeutic target in
Zimmermann JSM; Linxweiler J; Radosa JC; Linxweiler M; Zimmermann R
Front Physiol; 2022; 13():1014271. PubMed ID: 36262254
[TBL] [Abstract][Full Text] [Related]
12. Is Nucleoredoxin a Master Regulator of Cellular Redox Homeostasis? Its Implication in Different Pathologies.
Idelfonso-García OG; Alarcón-Sánchez BR; Vásquez-Garzón VR; Baltiérrez-Hoyos R; Villa-Treviño S; Muriel P; Serrano H; Pérez-Carreón JI; Arellanes-Robledo J
Antioxidants (Basel); 2022 Mar; 11(4):. PubMed ID: 35453355
[TBL] [Abstract][Full Text] [Related]
13. Pyroptosis-Related Risk Signature Exhibits Distinct Prognostic, Immune, and Therapeutic Landscapes in Hepatocellular Carcinoma.
Zhao Y; Song Q; Xu F; Zhou Y; Zuo X; Zhang Z
Front Genet; 2022; 13():823443. PubMed ID: 35368686
[No Abstract] [Full Text] [Related]
14. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
[TBL] [Abstract][Full Text] [Related]
15. Complexity and Specificity of Sec61-Channelopathies: Human Diseases Affecting Gating of the Sec61 Complex.
Sicking M; Lang S; Bochen F; Roos A; Drenth JPH; Zakaria M; Zimmermann R; Linxweiler M
Cells; 2021 Apr; 10(5):. PubMed ID: 33925740
[TBL] [Abstract][Full Text] [Related]
16. SEC61G is upregulated and required for tumor progression in human kidney cancer.
Meng H; Jiang X; Wang J; Sang Z; Guo L; Yin G; Wang Y
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33846795
[TBL] [Abstract][Full Text] [Related]
17. SEC61G plays an oncogenic role in hepatocellular carcinoma cells.
Gao H; Niu W; He Z; Gao C; Peng C; Niu J
Cell Cycle; 2020 Dec; 19(23):3348-3361. PubMed ID: 33171060
[TBL] [Abstract][Full Text] [Related]
18. Differential expression and diagnostic significance of P53, MutS homologs 2, tropomyosin-4 in alpha-fetoprotein-negative hepatocellular carcinoma.
Gong X; Huang A
J Clin Lab Anal; 2020 Aug; 34(8):e23353. PubMed ID: 32363617
[TBL] [Abstract][Full Text] [Related]
19. Different responses to anti-programmed cell death protein 1 (PD-1) immunotherapy in a patient with Lynch syndrome and metachronous urothelial and colon cancer: A case report.
Feng Y; Cao Y; Yuan M; Chen R; Ji X; Hu X
Oncol Lett; 2019 Nov; 18(5):5085-5090. PubMed ID: 31612019
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
